|
US20050054682A1
(en)
*
|
1996-01-04 |
2005-03-10 |
Phillips Jeffrey O. |
Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
|
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
SE9600071D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients I
|
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
|
WO1998023272A1
(en)
*
|
1996-11-27 |
1998-06-04 |
The Procter & Gamble Company |
Compositions and methods for the treatment of gastrointestinal disorders
|
|
MX9703918A
(es)
*
|
1997-05-28 |
1998-11-30 |
J Marshall M D Barry |
Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
|
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
|
AU8354498A
(en)
*
|
1997-08-25 |
1999-03-16 |
Procter & Gamble Company, The |
Combined preparations for treating upper gastrointestinal tract distress
|
|
ES2216351T3
(es)
*
|
1997-12-08 |
2004-10-16 |
Altana Pharma Ag |
Nueva forma de supositorio que comprende un compuesto activo labil o acidos.
|
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
|
FR2774906B1
(fr)
*
|
1998-02-13 |
2000-05-12 |
Rhodia Chimie Sa |
Systeme d'encapsulation a coeur organique et a ecorce minerale a base d'hydroxycarbonate d'aluminium et son procede de preparation
|
|
CN1195500C
(zh)
|
1998-05-18 |
2005-04-06 |
武田药品工业株式会社 |
可口腔崩解的片剂
|
|
US7122207B2
(en)
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
|
UA69413C2
(uk)
*
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
|
|
ATE481090T1
(de)
|
1998-07-28 |
2010-10-15 |
Takeda Pharmaceutical |
Leicht zerfallende feste zubereitung
|
|
SE9803772D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
|
IL145688A0
(en)
*
|
1999-03-29 |
2002-06-30 |
American Home Prod |
Coating system
|
|
JP2003504338A
(ja)
*
|
1999-07-12 |
2003-02-04 |
スミスクライン・ビーチャム・コーポレイション |
胸やけの処置法
|
|
US7220762B1
(en)
|
1999-10-20 |
2007-05-22 |
Eisai R&D Management Co., Ltd. |
Methods for stabilizing benzimidazole compounds
|
|
US20040191276A1
(en)
*
|
1999-11-30 |
2004-09-30 |
Cutispharma, Inc. |
Compositions and kits for compounding pharmaceuticals
|
|
AU2001296908A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Geneva Pharmaceuticals, Inc. |
Proton pump inhibitor formulation
|
|
US20020192299A1
(en)
*
|
2000-12-28 |
2002-12-19 |
Rajneesh Taneja |
Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
|
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
IL159584A0
(en)
*
|
2001-07-16 |
2004-06-01 |
Astrazeneca Ab |
Pharmaceutical formulation comprising a proton pump inhibitor and antacids
|
|
AR036354A1
(es)
*
|
2001-08-31 |
2004-09-01 |
Takeda Chemical Industries Ltd |
Preparacion solida
|
|
CA2461682A1
(en)
|
2001-09-28 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Composite dosage forms
|
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
|
US7008777B2
(en)
|
2001-10-15 |
2006-03-07 |
Barry J. Marshall |
System for the detection of urease and method for using same
|
|
US6929926B2
(en)
|
2001-10-15 |
2005-08-16 |
Barry J. Marshall |
Composition for the detection of gastrointestinal disorders
|
|
CA2472103A1
(en)
*
|
2002-01-25 |
2003-08-07 |
Santarus, Inc. |
Transmucosal delivery of proton pump inhibitors
|
|
KR100479637B1
(ko)
*
|
2002-02-01 |
2005-03-31 |
한국화학연구원 |
란소프라졸을 함유하는 경구제제 및 그의 제조방법
|
|
CO5400144A1
(es)
*
|
2002-03-11 |
2004-05-31 |
Novartis Ag |
Compuestos organicos
|
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
|
US20040081700A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Dose titratable liquid dosage forms of acid labile drugs
|
|
US20040082618A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Liquid dosage forms of acid labile drugs
|
|
RU2211039C1
(ru)
*
|
2002-08-01 |
2003-08-27 |
Наркевич Владимир Эдуардович |
Антацидный препарат многослойного действия "полигель" для лечения язвенной болезни желудка и двенадцатиперстной кишки
|
|
US6663892B1
(en)
*
|
2002-08-19 |
2003-12-16 |
L. Perrigo Company |
Multiple portion tablet
|
|
CA2771725C
(en)
|
2002-10-16 |
2015-08-18 |
Takeda Pharmaceutical Company Limited |
Solid preparation comprising a non-toxic base and a proton pump inhibitor
|
|
SE0203065D0
(sv)
*
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
|
US9107804B2
(en)
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
|
US20070243251A1
(en)
*
|
2002-12-20 |
2007-10-18 |
Rajneesh Taneja |
Dosage Forms Containing A PPI, NSAID, and Buffer
|
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
|
US7258981B2
(en)
*
|
2003-01-24 |
2007-08-21 |
Clontech Laboratories, Inc. |
Sensitive proteasome sensor constructs and methods for their design and use
|
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
|
CA2517005A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Santarus, Inc. |
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
|
EP1759692A3
(en)
*
|
2003-03-10 |
2007-09-12 |
Novartis AG |
Taste-masked solid veterinary compositions
|
|
WO2004082692A1
(ja)
*
|
2003-03-18 |
2004-09-30 |
Kowa Co., Ltd. |
制酸剤組成物
|
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
|
AR045062A1
(es)
*
|
2003-07-18 |
2005-10-12 |
Santarus Inc |
Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
|
|
US8993599B2
(en)
*
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
AR045061A1
(es)
*
|
2003-07-18 |
2005-10-12 |
Santarus Inc |
Formulacion farmaceutica y metodo para tratar trastornos gastrointestinales causados por acido
|
|
US20060165793A1
(en)
*
|
2003-08-04 |
2006-07-27 |
Koji Ukai |
Pharmaceutical preparation to be dispersed before administration
|
|
US7282050B2
(en)
*
|
2003-10-31 |
2007-10-16 |
Medtronic, Inc. |
Ablation of exterior of stomach to treat obesity
|
|
US7252665B2
(en)
*
|
2003-10-31 |
2007-08-07 |
Medtronic, Inc |
Ablation of stomach lining to reduce stomach acid secretion
|
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
|
US7041124B2
(en)
*
|
2003-12-23 |
2006-05-09 |
Kimberly-Clark Worldwide, Inc. |
System and method for providing therapy to a portion of a body
|
|
GB0403165D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Ct |
Novel uses for proton pump inhibitors
|
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
RU2288725C2
(ru)
*
|
2004-05-31 |
2006-12-10 |
Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") |
Твердая лекарственная форма, проявляющая антацидное действие
|
|
EP1753405A4
(en)
*
|
2004-06-10 |
2008-09-17 |
Glatt Air Tech Inc |
SLOW RELEASE PHARMACEUTICAL PREPARATION
|
|
US20050281876A1
(en)
*
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
|
GB2418854B
(en)
*
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
|
EP2417969A1
(en)
|
2004-10-21 |
2012-02-15 |
Aptalis Pharmatech, Inc. |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
|
US20060165797A1
(en)
*
|
2005-01-12 |
2006-07-27 |
Pozen Inc. |
Dosage form for treating gastrointestinal disorders
|
|
US8673352B2
(en)
*
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
|
SE530605C2
(sv)
*
|
2005-09-29 |
2008-07-15 |
Barbara Nelson |
Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar
|
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
|
SG184754A1
(en)
*
|
2005-12-28 |
2012-10-30 |
Takeda Pharmaceutical |
Controlled release solid preparation
|
|
WO2007112581A1
(en)
*
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Controlled release delivery device comprising an organosol coat
|
|
WO2007122478A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Themis Laboratories Private Limited |
Multiple unit compositions
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
EP2026768B1
(en)
*
|
2006-06-01 |
2018-02-28 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
|
AR056062A1
(es)
|
2006-06-05 |
2007-09-19 |
Bago Sa Labor |
Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
|
|
CN101120930B
(zh)
*
|
2006-08-11 |
2010-09-29 |
石药集团中奇制药技术（石家庄）有限公司 |
一种奥美拉唑组合物及其制备方法
|
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
|
CN101259140B
(zh)
*
|
2007-03-08 |
2012-08-22 |
重庆北碚现代应用药物研究所 |
一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
|
|
AU2007352872B2
(en)
*
|
2007-05-07 |
2013-03-14 |
Evonik Operations Gmbh |
Solid dosage forms comprising an enteric coating with accelerated drug release
|
|
EP2044929A1
(en)
*
|
2007-10-04 |
2009-04-08 |
Laboratorios del Dr. Esteve S.A. |
Oral fast distintegrating tablets
|
|
ITFI20070253A1
(it)
*
|
2007-11-09 |
2009-05-10 |
Valpharma Internat S P A |
Formulazioni farmaceutiche per la somministrazione di ipp.
|
|
CN101980700A
(zh)
|
2008-02-20 |
2011-02-23 |
密苏里大学董事会 |
包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
|
|
EP2127643A1
(de)
*
|
2008-05-30 |
2009-12-02 |
Bayer Schering Pharma Aktiengesellschaft |
Orale Pelletformulierungen mit zeitversetzter Wirkstofffreigabe
|
|
EA201100313A1
(ru)
|
2008-09-09 |
2011-10-31 |
Астразенека Аб |
Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
|
|
WO2010038241A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Panacea Biotec Limited |
Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid
|
|
JP2012072061A
(ja)
*
|
2009-01-29 |
2012-04-12 |
Eisai R & D Management Co Ltd |
新規組成物
|
|
US20110008432A1
(en)
*
|
2009-06-25 |
2011-01-13 |
Pozen Inc. |
Method for Treating a Patient in Need of Aspirin Therapy
|
|
CA2764963C
(en)
|
2009-06-25 |
2016-11-01 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
|
WO2011067667A2
(en)
|
2009-12-02 |
2011-06-09 |
Eurand Pharmaceuticals Limited |
Fexofenadine microcapsules and compositions containing them
|
|
EP2519229A2
(en)
|
2009-12-29 |
2012-11-07 |
Novartis AG |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
|
UY33173A
(OSRAM)
*
|
2010-01-08 |
2011-07-29 |
Eurand Inc |
|
|
CN102844077A
(zh)
|
2010-04-23 |
2012-12-26 |
S-生物技术控股有限责任公司 |
一种用于中和胃酸的固体药物组合物
|
|
US9539214B2
(en)
|
2011-12-28 |
2017-01-10 |
Pozen Inc. |
Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
|
US20140127296A1
(en)
*
|
2012-11-05 |
2014-05-08 |
Kenneth John Tibbs |
Pharmaceutical preparation and method for treatment of diabetes
|
|
US20150238514A1
(en)
*
|
2014-02-21 |
2015-08-27 |
William Armstrong |
Protective Supplement Configuration
|
|
WO2016174664A1
(en)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
US20190151297A1
(en)
*
|
2016-04-29 |
2019-05-23 |
Nauts Equine Brand Pty Ltd |
Veterinary Composition
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
TR201723199A2
(tr)
*
|
2017-12-30 |
2019-07-22 |
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi |
Yeni farmasötik bileşimler.
|
|
KR102080023B1
(ko)
*
|
2018-01-29 |
2020-02-21 |
주식회사 종근당 |
에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
|
|
KR102006777B1
(ko)
|
2018-01-29 |
2019-10-08 |
주식회사 종근당 |
에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
|
|
JP2021533177A
(ja)
*
|
2018-08-23 |
2021-12-02 |
チョン クン ダン ファーマシューティカル コーポレイション |
エソメプラゾール及び炭酸水素ナトリウムを含む、優れた溶解特性を備えた薬学的製剤
|
|
BR112022007223A2
(pt)
*
|
2019-10-17 |
2022-07-05 |
Hanmi Pharm Ind Co Ltd |
Composição farmacêutica e formulação de combinação farmacêutica
|
|
CN114980867B
(zh)
*
|
2020-01-23 |
2024-03-15 |
韩美药品株式会社 |
包含质子泵抑制剂和抗酸剂的药物复合制剂
|
|
PH12022551738A1
(en)
*
|
2020-01-23 |
2023-11-13 |
Hanmi Pharmaceutical Co Ltd |
Pharmaceutical composite formulation comprising proton pump inhibitor and antacid
|
|
KR102608889B1
(ko)
*
|
2020-07-14 |
2023-12-04 |
한미약품 주식회사 |
프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제 및 그의 제조방법
|
|
WO2022103233A1
(ko)
*
|
2020-11-13 |
2022-05-19 |
(주)휴온스 |
라베프라졸 및 제산제를 포함하는 약제학적 복합제제 및 이의 제조방법
|
|
CN114569579B
(zh)
|
2020-12-02 |
2023-10-31 |
丽珠医药集团股份有限公司 |
肠溶微丸、其制备方法和包含它的制剂
|
|
KR20230097346A
(ko)
*
|
2021-12-24 |
2023-07-03 |
한미약품 주식회사 |
프로톤 펌프 저해제 및 제산제를 포함하는 경구용 복합정제의 제조방법 및 이에 의해 제조된 경구용 복합정제
|
|
KR102553713B1
(ko)
*
|
2022-11-18 |
2023-07-10 |
고덕상 |
미네랄 촉매제를 이용한 양식어류사료 제조방법
|